* Prestige Consumer Healthcare Inc PBH.N PBH is expected
to show a rise in quarterly revenue when it reports results on
May 14 for the period ending March 31 2024
* The Tarrytown New York-based company is expected to
report a
0.6% increase in revenue to $287.467 million from $285.87
million a year ago, according to the mean estimate from 6
analysts, based on LSEG data.The company's guidance on February
8 2024, for the period ended March 31, was for revenue of
$287.000 million.
* LSEG's mean analyst estimate for Prestige Consumer
Healthcare
Inc is for earnings of $1.14 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prestige
Consumer
Healthcare Inc is $75.00, above its last closing price
of $70.39.
The company's guidance on February 8 2024 for the period ended
March 31 was for gross profit margin of USD55.5%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 1.04 1.04 1.06 Beat 1.8
Sep. 30 2023 1.07 1.07 1.07 Met 0.3
Jan. 1 0001 1.01 1.01 1.06 Beat 5
Mar. 31 2023 1.04 1.04 -4.83 Missed -564.4
Dec. 1.01 1.01 1.04 Beat 2.6
31 2022
Sep. 30 2022 1.00 1.00 1.02 Beat 1.8
Jun. 30 2022 1.04 1.04 1.09 Beat 5
Mar. 31 2022 0.89 0.89 0.91 Beat 2.6
This summary was machine generated May 10 at 21:45 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)